Cargando…

In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation

BACKGROUND: Cannabis has been used worldwide for centuries for industrial, recreational and medicinal use, however, to date no successful attempts at editing genes involved in cannabinoid biosynthesis have been reported. This study proposes and develops an in silico best practices approach for the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Matchett-Oates, L., Braich, S., Spangenberg, G. C., Rochfort, S., Cogan, N. O. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457487/
https://www.ncbi.nlm.nih.gov/pubmed/34551006
http://dx.doi.org/10.1371/journal.pone.0257413
_version_ 1784571108190584832
author Matchett-Oates, L.
Braich, S.
Spangenberg, G. C.
Rochfort, S.
Cogan, N. O. I.
author_facet Matchett-Oates, L.
Braich, S.
Spangenberg, G. C.
Rochfort, S.
Cogan, N. O. I.
author_sort Matchett-Oates, L.
collection PubMed
description BACKGROUND: Cannabis has been used worldwide for centuries for industrial, recreational and medicinal use, however, to date no successful attempts at editing genes involved in cannabinoid biosynthesis have been reported. This study proposes and develops an in silico best practices approach for the design and implementation of genome editing technologies in cannabis to target all genes involved in cannabinoid biosynthesis. RESULTS: A large dataset of reference genomes was accessed and mined to determine copy number variation and associated SNP variants for optimum target edit sites for genotype independent editing. Copy number variance and highly polymorphic gene sequences exist in the genome making genome editing using CRISPR, Zinc Fingers and TALENs technically difficult. Evaluation of allele or additional gene copies was determined through nucleotide and amino acid alignments with comparative sequence analysis performed. From determined gene copy number and presence of SNPs, multiple online CRISPR design tools were used to design sgRNA targeting every gene, accompanying allele and homologs throughout all involved pathways to create knockouts for further investigation. Universal sgRNA were designed for highly homologous sequences using MultiTargeter and visualised using Sequencher, creating unique sgRNA avoiding SNP and shared nucleotide locations targeting optimal edit sites. CONCLUSIONS: Using this framework, the approach has wider applications to all plant species regardless of ploidy number or highly homologous gene sequences. SIGNIFICANCE STATEMENT: Using this framework, a best-practice approach to genome editing is possible in all plant species, including cannabis, delivering a comprehensive in silico evaluation of the cannabinoid pathway diversity from a large set of whole genome sequences. Identification of SNP variants across all genes could improve genome editing potentially leading to novel applications across multiple disciplines, including agriculture and medicine.
format Online
Article
Text
id pubmed-8457487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84574872021-09-23 In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation Matchett-Oates, L. Braich, S. Spangenberg, G. C. Rochfort, S. Cogan, N. O. I. PLoS One Research Article BACKGROUND: Cannabis has been used worldwide for centuries for industrial, recreational and medicinal use, however, to date no successful attempts at editing genes involved in cannabinoid biosynthesis have been reported. This study proposes and develops an in silico best practices approach for the design and implementation of genome editing technologies in cannabis to target all genes involved in cannabinoid biosynthesis. RESULTS: A large dataset of reference genomes was accessed and mined to determine copy number variation and associated SNP variants for optimum target edit sites for genotype independent editing. Copy number variance and highly polymorphic gene sequences exist in the genome making genome editing using CRISPR, Zinc Fingers and TALENs technically difficult. Evaluation of allele or additional gene copies was determined through nucleotide and amino acid alignments with comparative sequence analysis performed. From determined gene copy number and presence of SNPs, multiple online CRISPR design tools were used to design sgRNA targeting every gene, accompanying allele and homologs throughout all involved pathways to create knockouts for further investigation. Universal sgRNA were designed for highly homologous sequences using MultiTargeter and visualised using Sequencher, creating unique sgRNA avoiding SNP and shared nucleotide locations targeting optimal edit sites. CONCLUSIONS: Using this framework, the approach has wider applications to all plant species regardless of ploidy number or highly homologous gene sequences. SIGNIFICANCE STATEMENT: Using this framework, a best-practice approach to genome editing is possible in all plant species, including cannabis, delivering a comprehensive in silico evaluation of the cannabinoid pathway diversity from a large set of whole genome sequences. Identification of SNP variants across all genes could improve genome editing potentially leading to novel applications across multiple disciplines, including agriculture and medicine. Public Library of Science 2021-09-22 /pmc/articles/PMC8457487/ /pubmed/34551006 http://dx.doi.org/10.1371/journal.pone.0257413 Text en © 2021 Matchett-Oates et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Matchett-Oates, L.
Braich, S.
Spangenberg, G. C.
Rochfort, S.
Cogan, N. O. I.
In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title_full In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title_fullStr In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title_full_unstemmed In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title_short In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
title_sort in silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457487/
https://www.ncbi.nlm.nih.gov/pubmed/34551006
http://dx.doi.org/10.1371/journal.pone.0257413
work_keys_str_mv AT matchettoatesl insilicoanalysisenablinginformeddesignforgenomeeditinginmedicinalcannabisgenefamiliesandvariantcharacterisation
AT braichs insilicoanalysisenablinginformeddesignforgenomeeditinginmedicinalcannabisgenefamiliesandvariantcharacterisation
AT spangenberggc insilicoanalysisenablinginformeddesignforgenomeeditinginmedicinalcannabisgenefamiliesandvariantcharacterisation
AT rochforts insilicoanalysisenablinginformeddesignforgenomeeditinginmedicinalcannabisgenefamiliesandvariantcharacterisation
AT cogannoi insilicoanalysisenablinginformeddesignforgenomeeditinginmedicinalcannabisgenefamiliesandvariantcharacterisation